Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer

✍ Scribed by Fabrice Pierre; Peter C. Chua; Sean E. O’Brien; Adam Siddiqui-Jain; Pauline Bourbon; Mustapha Haddach; Jerome Michaux; Johnny Nagasawa; Michael K. Schwaebe; Eric Stefan; Anne Vialettes; Jeffrey P. Whitten; Ta Kung Chen; Levan Darjania; Ryan Stansfield; Joshua Bliesath; Denis Drygin; Caroline Ho; May Omori; Chris Proffitt; Nicole Streiner; William G. Rice; David M. Ryckman; Kenna Anderes

• Book ID: 106459621
• Publisher: Springer
• Year: 2011
• Tongue: English
• Weight: 446 KB
• Volume: 356
• Category: Article
• ISSN: 0300-8177
• DOI: 10.1007/s11010-011-0956-5